The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada

BACKGROUND: Hepatitis C virus (HCV) has high global prevalence and can lead to liver complications and death. Access to direct-acting antivirals (DAAs) in Canada increased following several policy changes, however the real-world impact of expanded DAA access and increased use of these drugs is unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Cherry, Gomes, Tara, Antoniou, Tony, Wong, William W. L., Janjua, Naveed, Guertin, Jason Robert, Schwartz, Kevin L., Feld, Jordan, Kwong, Jeff, Tadrous, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409286/
https://www.ncbi.nlm.nih.gov/pubmed/37552677
http://dx.doi.org/10.1371/journal.pone.0284914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409286/
https://www.ncbi.nlm.nih.gov/pubmed/37552677
http://dx.doi.org/10.1371/journal.pone.0284914

Ejemplares similares